oxEVOL
Oxodrol-12 +Liver Support
Superdrol/Oxodrol (12mg)
Liver Support
Gonad Axis Support
Guaranteed Potency
DHB Complex
IN STOCK
Oxevol-TM has been specifically designed as a mass and strength building compound. When present in an appropriate caloric environment, one rich in protein and low glycemic carbohydrates, Oxevol-TM can produce astonishing results in less than one month.
Oxevol-TM employs enzyme blocking herbs, whose function is to bind with and remove destructive CYP and P-450 liver enzymes from the body. The reason for removing these enzymes is that these same enzymes are responsible for destroying anabolic compounds as they pass through the liver, before entering the bloodstream. Removing these enzymes clears the way for the active anabolic ingredient to travel into the bloodstream with little or no interference, increasing the effectiveness of anabolic agents like Oxevol by as much as 40%!
Oxevol-TM is an extremely anabolic compound shown to be at least 4x as anabolic as the previously available “Banned Andros”, while being 30% less androgenic. Oxevol-TM has virtually no ability to be aromatized into estrogen, and very few side effects including little or no effect on body-hair, aggression, acne, water retention etc.
Dosages range from as little as one capsule per day for athletes under 200 lbs, to two capsules for those exceeding 200 lbs.
Supplement Facts:
Serving Size: 2 Capsules
Servings Per Container: 30
Amount Per Serving:
Vitamin B12 12mcg 200%
Vitamin C 60mg 100%
Vanadyl 4mg
2a-Dimethyl-17B-Hydroxy-5a-Ethiocholan-3-one 12mg
Anabolic Multiplier Proprietary Complex 2,500mcg (Bergamottin, Hoelen, Bupleurum)
Gonad Axis Proprietary Complex 2,000mcg (Tribulus 40%, Kudzu, Maca, Dodder Seed)
Liver Assist & Antioxidant Proprietary Blend 4,100mcg (Milk Thistle, Green Tea, Alpha Lipoic Acid, MSM, Ginger)
Red Kidney Bean 100mg
Other Ingredients: Gelatin, Di-Calcium Phosphate, Microcrystalline Cellulose, Stearic Acid, Magnesium Stearate.
This product was added to our catalog on Wednesday 07 February, 2007.
